The enhancer of rudimentary, e(r), gene encodes a small highly conserved protein, enhancer of rudimentary homolog (ERH), which has been shown to have a regulatory function in cell division, Notch signaling, and cancer progression. Human and Drosophila ERH, both 104 amino acids in length, are 76% identical and 84% similar. The high sequence identity translates into nearly identical tertiary structures. Previous studies on the expression of the human and Drosophila e(r) genes reveal that the two genes are similarly regulated. Data in the present study using an e(r)-eGFP reporter gene confirm these results, showing a high expression of the reporter in the ovaries, testes, and brain. The high structural and regulatory conservation of e(r) and ERH argue that human and Drosophila ERH may be biochemically and functionally equivalent. To test this hypothesis, a chimeric transgene containing the Drosophila e(r) non-coding regions and the human e(r) coding region was constructed and used to establish transgenic Drosophila stocks. This transgene can rescue all of the mutant phenotypes of an e(r) deletion, and Drosophila stocks in which the fly ERH has been replaced with the human ERH are fully healthy and viable. These studies demonstrate that the human and Drosophila ERH are functionally equivalent, suggesting that studies on the activity of the human ERH can be done in Drosophila, where a multitude of genetic and developmental tools are available.
Introduction
Since its discovery (1, 2), the enhancer of rudimentary gene, e(r), has been studied with respect to a role in mitosis, cell proliferation, and cancer. The e(r) gene was first shown to be expressed at high levels in oogenesis and in mitotic cells in the Drosophila embryo (2, 3, 4). The expression pattern in the embryo is very similar to that of cyclin E (5) and correlates with cells that are undergoing DNA synthesis (6) . These similarities suggest a role for e(r) in the cell cycle and DNA replication. This association with cell proliferation and DNA synthesis was first suggested genetically, when e(r) was identified as a positive regulator of rudimentary, r, the gene that codes for the first three enzymes in pyrimidine biosynthesis (2, 7). The human homologue of r, CAD, is highly expressed in dividing cells (8, 9, 10) . Likewise, human e(r) is expressed at high levels in dividing cells (11) and has been shown to regulate the splicing of the pre-mRNA of CENP-E, a mitotic-motor-protein gene, indicating an important mitotic function (12) .
The high expression of e(r) in dividing cells has led to the possibility that it may have a role in cancer. This appears to be the case. Human e(r) is expressed at high levels in cancerous tissue vs. normal tissue (11) .
In particular, e(r) expression increases with the tumorigenic progression of human breast cancer and ovarian cancer cells, which has led to the hypothesis that ERH expression may be diagnostic for human cancer progression (11) . It also presents the intriguing possibility that high levels of ERH are necessary for tumor progression.
The necessity for e(r) expression in cancer has been examined with RNAi approaches.
In mRNA knockdown experiments with shRNA, e(r) was identified as a gene whose expression was necessary for the proliferation of pancreatic, breast, and ovarian cancer cell lines (13) .
Similarly, e(r) mRNA knockdown decreased the viability of certain colorectal cancer cells with activated RAS mutations (12) . This study also showed that lower ERH expression correlated with increased survival of patients with tumors carrying activated RAS mutations. Together these studies reveal that e(r) activity is necessary for the proliferation of certain types of cancers.
Besides the conserved expression in dividing cells, other patterns of the expression of e(r) may be conserved. E(r) is expressed at high levels in developing ovaries in Drosophila (3). In humans, e(r) is also expressed at high levels in ovaries as well as testes (11) . Similarly, in the mouse, Mus musculus, a microarray analysis of genes expressed in the developing embryonic ovaries and testes showed that among transcripts e(r) ranked in the 97 th percentile for expression in the ovary and the testes (14, 15) . Thus e(r) is being expressed at high levels in the ovaries in three distantly related taxa, and in the testes in humans and mice.
The protein encoded by e(r) has been named ERH, enhancer of rudimentary homolog. It is a small highly conserved protein (2, 16, 17) .
The Drosophila melanogaster ERH is 76% identical to the vertebrate ERH, 49% identical to the nematode ERH, and 40% identical to the Arabidopsis ERH.
A high sequence conservation is seen within the vertebrates, with the human and mouse protein being identical and differing from the zebrafish protein by a single conservative amino acid change (valine to isoleucine) (17) .
The similarities in the expression of the human and Drosophila e(r) genes and the high conservation in the primary structure of the ERH, suggest that ERH may 2 Copyright 2016 Internal Medicine Review. All Rights Reserved Internal Medicine Review The human and Drosophila ERH are functionally equivalent: Evidence from transgenic studies September 2016 be biochemically and functionally equivalent in both species. In this paper we examine this hypothesis by first taking a closer look at the structure of the two proteins, second extending the comparison of the expression patterns, and finally using a human e(r) transgene to show that the human ERH can functionally replace the Drosophila ERH. These data reveal the functional equivalence of the two proteins, and support the proposal that certain aspects of the human ERH activity and its regulation can be examined using the Drosophila model system.
Evolutionary conservation between the human and Drosophila ERH
The human and Drosophila ERH are both 104 amino acids in length and share a 76% identity and an 83% similarity (16, 17) . A closer pairwise comparison along the length of the 104 amino acids shows other striking similarities. The positions of key groups of amino acids -hydrophobic amino acids, acidic amino acids, basic amino acids, and prolines are highly conserved between the two proteins ( Fig. 1 a-d) .
These similarities in the primary structures lead to the prediction that the human and Drosophila proteins fold into very similar tertiary structures. The mouse and human ERH (They are identical.) have been synthesized in bacteria, purified, and their tertiary structure determined (18, 19) . The protein folds into a single domain with a β-sheet formed by four β-strands (Fig. 1g) . This flat surface is involved in the dimerization of the protein. There are also three α-helices that contribute to the globular shape of the protein. The web server SWISS-MODEL (20) was used to generate a predicted tertiary structure of the Drosophila ERH. SWISS-MODEL uses an evolutionary modeling approach, knowledge of protein structure, and solved tertiary structures as references, to predict unknown structures. As was expected from the conserved features of the primary structures, the predicted structure of the Drosophila ERH (Fig. 1h) is highly similar to the solved human structure (Fig. 1g) . Both have the β-sheet involved in protein binding and the three α-helices.
The high similarities in the primary and tertiary structures of the human and Drosophila ERH suggest that the two proteins have similar biochemical functions and regulatory features.
Two other conserved features between these two proteins support this proposal. First, two casein kinase II sites that have been shown to be important in the regulation of the Drosophila ERH (21) are also present in the human ERH (Fig. 1e ). This suggests that the human ERH may be regulated by casein kinase II in a similar manner to the Drosophila ERH. Second, seven amino acids (5I, 7L, 17R, 19Y, 21D, 70L, 79Y) were shown to be highly important in the dimerization of the human ERH (18) . Six out of the seven of these sights are strictly conserved between human and Drosophila (Fig. 1f) . The one amino acid that is not conserved is a leucine to methionine substitution, which is a conservative substitution and could be serving the same function in the Drosophila ERH. 
Construction of transgenes used in this study
In order to examine the tissue distribution of e(r) and to test the functional equivalence of the human and Drosophila ERH, chimeric transgenes were constructed which consisted of the transcriptional and translational regulatory regions of the Drosophila e(r) gene and the protein coding regions of either the enhanced green fluorescent protein gene (eGFP) or the human e(r) gene. All of the transcriptional and translational regulatory regions of the Drosophila e(r) are contained within a 3.0-kb PvuII-SalI fragment (Fig. 2a) . The transgene that consists of this fragment is referred to as ER1 in this paper, and is used as a positive control for normal e(r) activity. This transgene rescues the null mutant Internal Medicine Review The human and Drosophila ERH are functionally equivalent: Evidence from transgenic studies September 2016 an "empty" e(r) gene (Fig. 2b) . This gene contains all of the non-coding DNA within the PvuII-SalI fragment, but is lacking the coding region for ERH. In its place is a unique NcoI restriction-enzyme site (CCATGG). This site was chosen because using it will retain the start codon (ATG) and the Drosophila translation signal (CACC) that immediately precedes the start codon. In practice, coding regions can be synthesized or amplified with PCR to contain an NcoI-compatible site at the 5'end and at the 3' end, immediately following the stop codon. The PCR approach was used to amplify the human e(r) coding region and the eGFP coding region using appropriate 5' (Table 1) in the creation of the two chimeric transgenes (Fig. 2 d & e) .
The significance of this approach to produce these e(r) transgenes, is that the inserted coding region will be regulated identically to the normal e(r) gene. For the eGFP transgene, this means that GFP can be used to examine the normal spatial distribution of ERH. For the human e(r) transgene, we can examine the ability of the human ERH to rescue the mutant e(r) phenotypes, when it is expressed at normal physiological levels, instead of overproduced levels. In this way we can more accurately compare the functionality of the human and Drosophila ERH. In the 5' primers, the start codon, ATG, is underlined. Human e(r) 5' contains a PciI site, ACATGT, necessary for retaining the second codon, TCT. eGFP 5' contains an NcoI site, CCATGG, for retaining the second codon, GTG. In the 3' primers, the stop codon (reverse complement), TTA, is underlined. The human e(r) cDNA and the eGFP cDNA were used as templates in the PCR.
e(r)-eGFP expression patterns
Drosophila stocks containing the e(r)-eGFP reporter gene, with the eGFP coding region under the control of the e(r) transcription and translation regulatory regions (Fig. 2e) , were used to determine the expression patterns of the e(r) gene. Three developmental stages were examined: preblastoderm embryos, 3 rd instar larvae, and adults.
Previous studies showed a high expression of e(r) in adult ovaries and in the blastoderm embryos (3), so we expected to see GFP expression in these tissues. As expected there is high expression in preblastoderm embryos (Fig 3 a & b) . This expression is the result of maternal expression of e(r)-eGFP and the deposition of the GFP mRNA and protein into the developing oocyte.
While GFP is distributed throughout the early embryo, there is a higher expression at the anterior and posterior poles. This is polar localization can be seen in both pictures, but is more distinct when an embryo is photographed at a reduced exposure (Fig.  3b) . While the cause of this localization is under investigation, we believe that it is the result of the localization of the e(r)-eGFP mRNA in the developing oocyte. This type of localization is common in Drosophila oocytes.
Examples are the anterior localization of the bicoid mRNA (22) and the posterior localization of the oskar mRNA (23) . If the e(r)-eGFP mRNA is being localized to the poles of the oocyte, then that indicates that there are mRNA localization signals within the e(r) mRNA.
Expression of GFP in adult flies was first examined in intact individuals. Both the adult female (Fig. 3c) and male (Fig. 3d) showed high GFP expression in the head and in the abdomen. The main organ in the head is the brain, and the main organs in the abdomen are the ovaries in females and the testes in males.
The abdomens were dissected and as expected, high expression was seen in the ovaries (Fig. 3e ) and the testes (Fig. 3f) . In the ovaries, expression appears to be higher in the early egg chambers to the right in the figure and lower in the more mature egg chambers to the left. This is consistent with the localization of e(r) mRNA which is present in the nurse cell of the developing egg chambers, and
deposited into the maturing oocyte (3). In the testes we see highest expression in the primary spermatocytes. The most apical region of the adult testis contains the spermatogonial cells that produce the primary spermatocytes via mitotic divisions. Adjacent to this region contains the developing primary spermatocytes, which will enter meiosis (24) . This apical region has low GFP expression, but the adjacent region corresponding to developing primary spermatocytes has high GFP expression (Fig. 3f) . Interestingly, studies in mice testes show that ERH is also localized to the developing spermatocytes (25).
Testes development begins in the larval stages, and by the 3 rd instar larval stage they are easily visible with the (a) (b) stereomicroscope through the body wall as large spheres, and are used to distinguish male and female larvae. GFP expression in whole male 3 rd instar larvae can clearly be seen in the developing testes (Fig. 3g) . Testes removed from the larvae show highest GFP expression in the region corresponding to primary spermatocytes (Fig. 3h) . This is in agreement with the GFP expression in the adult testis (Fig. 3f) . 3 rd Ovary development in female instar larvae is minimal compared to testis development in male 3 rd instar larvae, so the ovaries are not visible with a normal stereomicroscope. However, a small focus of GFP expression can be seen in female 3 rd instar larvae in the region where the ovaries should be present (Fig. 3i) . Expression of e(r) in the adult synaptic regions of the brain (Fig 4b) . This Drosophila brain had not been examined high expression in the adult brain is previously, so it was of interest to examine consistent with the high expression of ERH e(r)-eGFP expression in isolated brains. In in the embryonic and 3 rd instar larval brain this localization study an antibody to GFP and CNS (4) . Thus, as with ovaries and and a confocal microscope were used testes, we see a high expression in the brain instead of GFP fluorescence and a dissecting throughout the development of the fly. microscope.
Expression appears to be It should be noted that in human and ubiquitous in the brain and restricted mouse, e(r) is also expressed in the brain. In primarily to the cell bodies of the nerve cells human, northern blots and dot blots showed (Fig 4a) . Regions of the brain that show e(r) mRNA in the brain (11, 27 
Testing the functionality of the human ERH in Drosophila
The evolutionary conservation of the structures of the human and Drosophila ERH (Fig. 1) and the conserved aspects of the expression of the gene (Fig. 3 & 4) , strongly suggest that the two proteins are functionally equivalent. This possibility is supported by the fact that in human cells, the Drosophila ERH expressed from a Drosophila e(r) transgene, is nuclearly localized like its human counterpart (28). This means that Drosophila ERH must successfully interact with the nuclear localization system of the human ERH. In addition, the human and Drosophila ERH, both have RPS3 as a binding partner, and the Drosophila ERH can successfully interact with the human RPS3 in a yeast two-hybrid assay (28).
To test the functional equivalence of the human and Drosophila ERH, we constructed a human e(r) transgene that contains all of the non-coding regulatory regions of the Drosophila e(r) gene with the coding region of the human e(r) gene (Fig.  2d) . The significance of this construction is that it ensures that the human e(r) coding region will be expressed in an identical pattern to the normal Drosophila e(r) gene, and importantly at normal levels, rather than over-expressed levels. This chimeric e(r) gene was used to transform Drosophila melanogaster, and stocks containing an autosomal transgene were established. These transgenic stocks were used to test the ability of the human ERH to rescue the mutant phenotypes of an e(r) null mutation. mutant. The two e(r) alleles used in this study are both deletions and act as e(r) null alleles (3, Fig. 2a ).
For the rescue experiments, crosses were performed to produce flies which were missing the Drosophila e(r) gene, but which had the human e(r) transgene. As a positive control in all of the tests, stocks containing ER1, the Drosophila melanogaster e(r) transgene, were used to show rescue by the Drosophila melanogaster e(r) gene.
The human e(r) transgene rescues the

27-1 hd1
lethality of the e(r) r double mutant.
The original e(r) mutant allele, e(r) p1 , was isolated as an enhancer of the mutant wing phenotype of a rudimentary hd1 p1
allele, r (1, 2). It turned out e(r) was a leaky e(r) mutation, and that the combination of an e(r) null with r hd1 has a very low viability (Table 2) . Both e(r) and r are X-linked genes so the lethality of the 27-1 hd1 e(r) r double mutant can be assessed by the absence of the hemizygous males. Rescue of the lethality is seen by the presence of the double mutant males with the transgene. Heterozygous females from the crosses are used as a control for normal viability. As can be seen in Table 2 , two different human e(r) transgenes can rescue the double mutant lethality. As a control, the equivalent Drosophila melanogaster e(r) transgene, ER1, also rescues the double mutant lethality. The Male/Female ration shows that all three transgenes show good rescue. The lower than wild-type viability of these males is caused by the r hd1 mutation. The rescue in these experiments show that the human ERH can interact successfully with rudimentary and pyrimidine metabolism in Drosophila. (4) . Since both N and e(r) are X-linked genes, lethality of the double mutants is seen as the absence of hemizygous males (Table 3) . Heterozygous females are used as a control. Full viability of the hemizygous males would produce equal numbers of males and females. The N nd-p e(r) double mutant is lethal. As a negative control the e(r)-eGFP transgene (Fig. 2e) used in the expression studies ( Fig.  3 & 4) did not rescue the lethality (Table 3) . Two different stocks carrying the Hs-ER transgene were used in this study, and in
both cases the lethality of N e(r) was rescued. The extent of the rescue as seen by the Male/Female rescue was similar to that seen with the Drosophila melanogaster e(r) transgene, ER1 (Table 3 ). The lower than wild-type viability of the transgenic males is caused by the N ndp mutation. The rescue in these experiments show that, in the interaction with the Notch signaling pathway in Drosophila, the human ERH functions normally.
nd-p 37-6 There is high expression e(r) in the developing ovaries (3, Fig. 3e ). Thus it is not unexpected that e(r) null females produce very few offspring. To test the ability of the human e(r) transgene to rescue the low fecundity of the e(r) females, stocks were constructed that were homozygous for both e(r) and an autosomal insertion of the human e(r) 10 Copyright 2016 Internal Medicine Review. All Rights Reserved
Internal Medicine Review The human and Drosophila ERH are functionally equivalent: Evidence from transgenic studies September 2016 transgene or the Drosophila e(r) transgene, ER1. Ten females of each stock were crossed to ten wild-type males, and allowed to lay eggs for ten days. The total number of adult progeny produced from these crosses was used as a measure of fecundity. Both human e(r) transgenes rescue the low fecundity at levels comparable to that of the Drosophila e(r) transgene (Table 4 ). These data indicate that the human ERH can perform the function in Drosophila that are necessary to produce normal female fecundity. This requires activity in the normal development of the ovaries. While null mutants of e(r) are not lethal, they have a low a low viability (3). This low viability is probably the result of the lack of e(r) activity in a number of different tissues. To test the ability of the human e(r) transgene to rescue this low viability, crosses were set up to produce e(r) hemizygous males with or without the e(r) transgene. If the e(r) transgene does not rescue the low viability, then these two groups of e(r) males should be present in equal amounts and in low numbers. If the e(r) transgene rescues the low viability, then the transgene containing males should be significantly greater in number than the males without the transgene. As a control for wild-type viability the e(r) 27 (Table 5 ). The number of transgene containing males was much greater than those of the e(r) 27 -1 males without the transgene, and were close to the numbers of the control females. As a positive control, the Drosophila e(r) transgene also showed rescue of the low viability of e(r) 27-1 males, at a similar level to the rescue seen by the human e(r) transgene. In both cases the number of transgene containing males was about six times that of the males without the transgene. 
Conclusions and Discussion
The different e(r) mutant phenotypes reveal the roles of e(r) in different aspects of Drosophila development and physiology and in different biochemical and signaling pathways. The rescue of all of these mutant phenotypes by the human e(r) transgene, at levels comparable to the Drosophila e(r) transgene, indicates that the human ERH can functionally replace the Drosophila ERH throughout the development of the fruit fly. In fact, we now maintain viable and healthy stocks of Drosophila melanogaster in which the Drosophila e(r) has been deleted and replaced with the human e(r) transgene used in this study. This means that we have not been able to identify any e(r) loss-offunction phenotypes that cannot be rescued by the human ERH. Thus, the human and Drosophila ERH are functionally equivalent within the fruit fly, Drosophila melanogaster.
There are other data that argue that the human and Drosophila ERH are performing similar functions. In Drosophila, its initial isolation as a regulator or pyrimidine biosynthesis and its . Enhancer of rudimentary , e(r) , a expression in dividing cells pointed to a role in DNA synthesis and mitosis (1, 2). This has also been noted in humans, where e(r) expression is associated with dividing cells, specifically cancer cells (11) , indicating a possible function in cancer progression. Consistent with this proposal is the evidence that down-regulation of e(r) by RNAi inhibits the progression of certain cancers (12, 13) , and low e(r) expression correlates with higher survival among patients with certain cancers (12) . Understanding the activity and regulation of ERH will be important in defining its role in cancer.
Given the functional equivalence of the human and Drosophila ERH, the various e(r) mutant phenotypes, and the assays for wild-type ERH activity in Drosophila, the Drosophila melanogaster system will be useful in dissecting human ERH activity.
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